Permikson Capsules 160 mg, No. 30

Permikson caps.

160mg No. 30

Name ENG

PERMIXON

Clinical and pharmacological group

Phytopreparation used for functional disorders of urination associated with benign prostatic hyperplasia

ATX code

Serenoa repens

Dosage

160mg

Structure

Active ingredient: creeping sawn fruit extract lipidosterol 160 mg

Indications

Benign prostatic hyperplasia (adenoma) stages I and II.

Contraindications

Individual hypersensitivity to drug components

INN / Active ingredient

Palms creeping fruits extra.

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 3 years

Specifications

Category

BPH

,

Impotence in men

Scope of the drug

Dermatology

Release form

Capsules

Manufacturer country

France

Package quantity, pcs

thirty

Scope of application

Andrology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Pierre Fabre Medicament Production

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

G04CX02 Palm tree creeping drug

Dosage form

Capsules

Packaging

Box

The target audience

Adult

Dosage (volume) of the substance in the preparation

lipidosterol extract of Serenoa repens fruit 160 mg

Expiration date in days

1095

Package weight, g

25

Mode of application

:

Inside, during meals, 160 mg (1 capsule) 2 times a day or once in the morning.

Pharmaco-therapeutic group

:

Prostate hyperplasia benign herbal remedy